ARTICLE | Clinical News
BioChem regulatory update
May 3, 1999 7:00 AM UTC
The European Union's Committee for Proprietary Medicinal Products (CPMP) recommended approval of BCHE's Zeffix lamivudine 3TC to treat chronic hepatitis B virus (HBV) infection. The CPMP requested o...